Cyclophosphamide (Sandoz Inc.)


Welcome to the PulseAid listing for the Cyclophosphamide drug offered from Sandoz Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc.
NON-PROPRIETARY NAME: cyclophosphamide
SUBSTANCE NAME: CYCLOPHOSPHAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRAVENOUS; ORAL
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-10-31
END MARKETING DATE: 0000-00-00


Cyclophosphamide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCyclophosphamide from Sandoz Inc.
LABELER NAME: Sandoz Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/25mL)
START MARKETING DATE: 2014-10-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0781-3233_428ac6d9-f555-1adc-e054-00144ff8d46c
PRODUCT NDC: 0781-3233
APPLICATION NUMBER: ANDA204555

Other CYCLOPHOSPHAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalCyclophosphamide
Baxter Healthcare CorporationCYCLOPHOSPHAMIDE
Physicians Total Care, Inc.Cyclophosphamide
Sandoz Inc.Cyclophosphamide
West-Ward Pharmaceuticals Corp.Cyclophosphamide